Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

Young Oncologist Brunch 3: Molecular Tumor Board: A luxury or a necessity?

Molecular Tumor Board: A luxury or a necessity?

Date

12 Sep 2022

Session

Young Oncologist Brunch 3: Molecular Tumor Board: A luxury or a necessity?

Topics

Clinical Research;  Cancer Biology;  Pathology/Molecular Biology;  Cancer Intelligence (eHealth, Telehealth Technology, BIG Data);  Multi-Disciplinary and Multi-Professional Cancer Care;  Molecular Oncology;  Genetic and Genomic Testing

Tumour Site

Presenters

Philippe Aftimos

Authors

P.G. Aftimos

Author affiliations

  • Clinical Trials Conduct Unit, Institute Jules Bordet, 1000 - Brussels/BE

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Discussion led by Chair

Presenter: Christoph Oing

Session: Young Oncologist Brunch 3: Molecular Tumor Board: A luxury or a necessity?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.